Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Globus Medical Inc (NY: GMED )

71.34 -0.39 (-0.54%)
Streaming Delayed Price Updated: 11:44 AM EDT, Aug 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 77,141
Open 71.85
Bid (Size) 71.31 (2)
Ask (Size) 71.36 (1)
Prev. Close 71.73
Today's Range 71.21 - 71.97
52wk Range 43.38 - 74.21
Shares Outstanding 135,407,017
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Globus Medical, Inc. (GMED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
GMED Investors Have Opportunity to Join Globus Medical, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire

Performance

YTD
+34.20%
+34.20%
1 Month
-0.34%
-0.34%
3 Month
+8.93%
+8.93%
6 Month
+26.42%
+26.42%
1 Year
+32.50%
+32.50%

More News

Read More
Globus Medical Launches ADIRA™ XLIF™ Plate System
From Globus Medical
Via GlobeNewswire
Looking Into Globus Medical's Recent Short Interest
Via Benzinga
What 8 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
NYSE:GMED is showing decent growth, but is still valued reasonably.
Via Chartmill
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
Via Chartmill
GLOBUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Globus Medical, Inc. on Behalf of Globus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Globus Medical, Inc. (GMED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Peering Into Globus Medical's Recent Short Interest
Via Benzinga
Where Globus Medical Stands With Analysts
Via Benzinga
NYSE:GMED is not too expensive for the growth it is showing.
Via Chartmill
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Globus Medical, Inc. (GMED)
From Kirby McInerney LLP
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
From Law Offices of Frank R. Cruz
Via Business Wire
Globus Medical (GMED) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
GMED Stock Earnings: Globus Medical Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Globus Medical Reports Second Quarter 2024 Results
From Globus Medical
Via GlobeNewswire
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
From Globus Medical
Via GlobeNewswire
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
Via Chartmill
Staar Surgical Stock Earns RS Rating Upgrade
Via Investor's Business Daily
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
Via Benzinga
Topics Economy
Exposures Interest Rates
Stryker Stock Sees RS Rating Treks Higher To 71
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.